Antiviral Activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the Alkaloid Lupinine
Zhangeldy S Nurmaganbetov, Oralgazy A Nurkenov, Andrei I Khlebnikov, Serik D Fazylov, Roza B Seidakhmetova, Zhanar K Tukhmetova, Altynaray T Takibayeva, Gaukhar Khabdolda, Zhanar B Rakhimberlinova, Aigul K Kaldybayeva, Elvira E Shults, Marilisa Leone · 2024
Read Antiviral Activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the Alkaloid Lupinine by Zhangeldy S Nurmaganbetov, Oralgazy A Nurkenov, Andrei I Khlebnikov, Serik D Fazylov, Roza B Seidakhmetova, Zhanar K Tukhmetova, Altynaray T Takibayeva, Gaukhar Khabdolda, Zhanar B Rakhimberlinova, Aigul K Kaldybayeva, Elvira E Shults, Marilisa Leone (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11644009.txt.
Description
Zhangeldy Nurmaganbetov and co-authors build flu fighters in 2024 from a plant alkaloid called lupinine. They attach a triazole ring to the natural compound and vary the attachments. The goal is a drug that kills flu virus particles directly, since few flu drugs exist and resistance keeps growing.
Several versions cut the infectivity of two flu strains, H1N1 and H3N2, when mixed with virus samples. Computer docking showed the compounds grip two key virus proteins, hemagglutinin and neuraminidase, which matches the lab results. Four compounds stood out as the best prospects. The team plans deeper cell and animal tests on those four.
Catalog record
| CREATOR | Zhangeldy S Nurmaganbetov, Oralgazy A Nurkenov, Andrei I Khlebnikov, Serik D Fazylov, Roza B Seidakhmetova, Zhanar K Tukhmetova, Altynaray T Takibayeva, Gaukhar Khabdolda, Zhanar B Rakhimberlinova, Aigul K Kaldybayeva, Elvira E Shults, Marilisa Leone |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |